1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6813F094F2F84783565257F1100457D40
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/developing-strong-internal-thought-leader-management-capabilities-inside-medical-affairs
18
19
203.231.229.89
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25BMR




Products & Services Medical Affairs Thought Leader Services

Developing Strong Internal Thought Leader Management Capabilities Inside Medical Affairs

ID: POP-267


Features:

19 Info Graphics

37 Data Graphics

400 Metrics

4 Narratives


Pages: 71


Published: 2015


Delivery Format: Shipped


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • STUDY SNAPSHOT
  • KEY FINDINGS
  • VIEW TOC AND LIST OF EXHIBITS
In pharma, regulatory and access restrictions have reshaped key interactions with thought leaders. As thought leaders play an integral role in every stage of the product lifecycle, it is critical for the Medical Affairs function to develop robust internal thought leader management capabilities.


Best Practices, LLC undertook this benchmarking study to explore how leading biopharmaceutical companies structure and organize their Medical Affairs function and develop effective relationships with thought leaders. The study also benchmarks the resource levels, internal communication tactics and use of social media for effective thought leader management.
Responses in this study have been presented in regional (US only and global companies) and company size (Large, medium-sized and small companies) segments.


Industries Profiled:
Biopharmaceutical; Biotech; Pharmaceutical; Manufacturing; Consumer Products; Diagnostic; Medical Device; Chemical; Health Care; Clinical Research; Laboratories


Companies Profiled:
Alkermes; Allergan; Baxalta; Bayer; Celldex Therapeutics; CSL Behring; Genentech; Genzyme; GW Pharmaceuticals; Indivior; Jazz Pharmaceuticals; Mesoblast; Neurocrine Biosciences; Norgine; Novo Nordisk; Perrigo Company; Pfizer; ProStrakan; Sanofi; Santen; Shire; Stallergenes; Sunovion; Teva Pharmaceutical Industries Ltd; Theravance; Tris Pharma; UCB Pharma

Study Snapshot

Best Practices, LLC engaged 31 executives from 27 leading biopharmaceutical companies through a benchmarking survey. 7 research participants represented large biopharmaceutical organizations, while the remaining benchmark class emerged from mid-size and small companies. Also 14 companies form a US-only segment, while 13 companies form a Global segment.

Key Findings

Budget and Functional Responsibilities Should Align: Ideally, companies should align budget management and functional responsibilities to use resources effectively. While Medical Affairs group leads Thought Leader Management in a majority of the companies, the group has less budget decision power than functional responsibility in this area.

Thought Leader Management Spend is Allocated to Most Important Activities: The importance level of an activity influences the amount of spend for it. For example: Funding Clinical Research Activities has the highest spend and is rated the most important activity by all segments.


Table of Contents

Executive Summary pgs. 3-11
Research Overview pg. 3
Participating Companies & Segmentation pg. 4-5
Key Recommendations pg. 6
Key Findings & Insights pgs. 7-10
Thought Leader Management Leadership and Responsibilities pgs. 11-16
Thought Leader Management Spend and Resource Allocation pgs. 17-22
Importance of Thought Leader Management Activities pgs. 23-27
Managing Thought Leader Interactions pgs. 28-33
Effectiveness of Coordination Methods pgs. 34-40
Social Media Impact on Thought Leader Management pgs. 41-45
Medical Affairs Structure and Leadership pgs. 46-48
Medical Affairs Spend Allocation and Importance of Functions pgs. 49-55
Medical Affairs Spend Ratios pgs. 56-61
Demographics pgs. 62-65
Appendix pg. 66-69

List of Charts & Exhibits

Leadership for Thought Leader Management
Functional and Budget Responsibility for Thought Leader management
Challenges and Success Factors in Developing and Maintaining Strong Thought Leader Management
Thought Leader Spend as Percent of Total Medical Affairs Spend
Percentage of the Total Thought Leader Management Spend Allocated to Listed Activities
Importance of Thought Leader Services to the Success of the Organization
Tactics to Overcome Access Challenges
Approaches Employed to Coordinate Thought Leader Management Resources Across Functions to Avoid Redundancy or Confusion
Increasing the Effective Use of CRM Tools
Effectiveness of Coordination Methods
Impact of Social Media on Thought Leader Management Activities
Effectiveness of Social Media Sources Used with Thought Leaders
Best Practices for Using Social Media with Thought Leaders
Challenges in Utilizing Social Media
Current Medical Affairs Structure
Challenges and Success Factors in Developing and Maintaining Strong Medical Affairs Capabilities
Importance and Spend Allocation for Medical Affairs
Percentage of the Total Medical Affairs Spend Allocated to Different Functions
Changes Expected in Budget and Full-time Employee (FTE) Resource Levels within the Next 12-24 Months
Percentage of Medical Affairs Functions' Spending Allocated to Outsourcing Expenses (Vendor Services)
Importance of Medical Affairs Functions to the Organization
Issues Affecting Change in Importance of Medical Affairs
Revenue per Medical Affairs FTE
Medical Affairs Spend Per In-Market Product
Medical Affairs Spend Per Pipeline Product
Medical Affairs Spend per MA FTE